View clinical trials related to Canthal Lines.
Filter by:This study to assess aesthetic improvement following treatment with QM1114-DP.
This double-blind study has two parts for each subject (same population): Part A: initial treatment in Lateral Canthal Lines (LCL) (placebo-controlled): - To assess the efficacy and safety of Azzalure® compared to placebo in the improvement of moderate to severe LCLs. - To assess the subjects' level of satisfaction with the appearance of their LCLs compared to placebo. Part B: repeated treatment in LCL with or without Glabellar Lines (GL) (active treatment, up to 1 year): - To assess safety of Azzalure® following repeated administration in the improvement of moderate to severe LCLs. - To assess the safety of Azzalure® when used concomitantly for improvement of moderate to severe LCLs and GLs. - To assess the subjects' level of satisfaction with the appearance of their LCLs.